CAH: Double-digit growth across all segments, robust specialty gains, and strong cash flow progress

All five segments delivered strong double-digit earnings growth, with specialty and pharma outperforming expectations. Strategic acquisitions and operational improvements are driving sustainable growth, while contract structures and a stable customer base support consistency. Cash flow targets are…